Neurocrine Biosciences, Inc. (NBIX)
150.66
-5.93
(-3.79%)
USD |
NASDAQ |
Nov 20, 16:00
150.66
0.00 (0.00%)
After-Hours: 16:05
Neurocrine Biosciences 30-Day Average Daily Volume : 1.406M for Nov. 19, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| November 19, 2026 | 1.406M |
| November 18, 2026 | 1.399M |
| November 17, 2026 | 1.383M |
| November 16, 2026 | 1.394M |
| November 13, 2026 | 1.406M |
| November 12, 2026 | 1.415M |
| November 11, 2026 | 1.438M |
| November 10, 2026 | 1.462M |
| November 09, 2026 | 1.476M |
| November 06, 2026 | 1.473M |
| November 05, 2026 | 1.462M |
| November 04, 2026 | 1.451M |
| November 03, 2026 | 1.434M |
| November 02, 2026 | 1.339M |
| October 30, 2026 | 1.318M |
| October 29, 2026 | 1.368M |
| October 28, 2026 | 1.380M |
| October 27, 2026 | 1.377M |
| October 26, 2026 | 1.382M |
| October 23, 2026 | 1.366M |
| October 22, 2026 | 1.361M |
| October 21, 2026 | 1.349M |
| October 20, 2026 | 1.357M |
| October 19, 2026 | 1.342M |
| October 16, 2026 | 1.339M |
| Date | Value |
|---|---|
| October 15, 2026 | 1.326M |
| October 14, 2026 | 1.315M |
| October 13, 2026 | 1.294M |
| October 12, 2026 | 1.300M |
| October 09, 2026 | 1.290M |
| October 08, 2026 | 1.281M |
| October 07, 2026 | 1.277M |
| October 06, 2026 | 1.273M |
| October 05, 2026 | 1.265M |
| October 02, 2026 | 1.248M |
| October 01, 2026 | 1.222M |
| September 30, 2026 | 1.192M |
| September 29, 2026 | 1.165M |
| September 28, 2026 | 1.154M |
| September 25, 2026 | 1.150M |
| September 24, 2026 | 1.180M |
| September 23, 2026 | 1.211M |
| September 22, 2026 | 1.179M |
| September 21, 2026 | 1.170M |
| September 18, 2026 | 1.156M |
| September 17, 2026 | 1.108M |
| September 16, 2026 | 1.112M |
| September 15, 2026 | 1.118M |
| September 14, 2026 | 1.124M |
| September 11, 2026 | 1.250M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Amgen, Inc. | 2.663M |
| BioCryst Pharmaceuticals, Inc. | 5.121M |
| Halozyme Therapeutics, Inc. | 2.350M |
| Iovance Biotherapeutics, Inc. | 13.77M |
| Precigen, Inc. | 6.548M |